BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 200 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,039,495 | +2.9% | 289,701 | +21.9% | 0.01% | 0.0% |
| Q1 2023 | $1,981,709 | -8.2% | 237,615 | +26.4% | 0.01% | -12.5% |
| Q4 2022 | $2,158,229 | +3.6% | 187,999 | +13.7% | 0.01% | 0.0% |
| Q3 2022 | $2,083,000 | -21.1% | 165,341 | -33.8% | 0.01% | -20.0% |
| Q2 2022 | $2,641,000 | +14.1% | 249,639 | +75.3% | 0.01% | +42.9% |
| Q1 2022 | $2,315,000 | -29.2% | 142,377 | -39.7% | 0.01% | -22.2% |
| Q4 2021 | $3,272,000 | +23.1% | 236,217 | +27.8% | 0.01% | +12.5% |
| Q3 2021 | $2,657,000 | -2.8% | 184,890 | +6.9% | 0.01% | -11.1% |
| Q2 2021 | $2,734,000 | +168.8% | 172,901 | +72.9% | 0.01% | +125.0% |
| Q1 2021 | $1,017,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $50,998,000 | 20.86% |
| RTW INVESTMENTS, LP | 3,458,120 | $29,048,000 | 7.65% |
| ISZO CAPITAL MANAGEMENT LP | 307,366 | $2,582,000 | 4.49% |
| DAFNA Capital Management LLC | 541,128 | $4,545,000 | 3.84% |
| RA Capital Management | 3,489,795 | $29,314,000 | 3.60% |
| EMORY UNIVERSITY | 375,348 | $3,153,000 | 2.98% |
| Ghost Tree Capital, LLC | 1,500,000 | $12,600,000 | 2.35% |
| ACUTA CAPITAL PARTNERS, LLC | 920,310 | $7,731,000 | 1.83% |
| Avoro Capital Advisors LLC | 1,603,001 | $13,465,000 | 1.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,085,236 | $25,916,000 | 1.00% |